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Abstract
Persistent infection by pathogenic organisms requires effective strategies for the defense of these organisms against the
host immune response. A common strategy employed by many pathogens to escape immune recognition and clearance is
to continually vary surface epitopes through recombinational shuffling of genetic information. Borrelia burgdorferi,a
causative agent of Lyme borreliosis, encodes a surface-bound lipoprotein, VlsE. This protein is encoded by the vlsE locus
carried at the right end of the linear plasmid lp28-1. Adjacent to the expression locus are 15 silent cassettes carrying
information that is moved into the vlsE locus through segmental gene conversion events. The protein players and molecular
mechanism of recombinational switching at vlsE have not been characterized. In this study, we analyzed the effect of the
independent disruption of 17 genes that encode factors involved in DNA recombination, repair or replication on
recombinational switching at the vlsE locus during murine infection. In Neisseria gonorrhoeae, 10 such genes have been
implicated in recombinational switching at the pilE locus. Eight of these genes, including recA, are either absent from B.
burgdorferi, or do not show an obvious requirement for switching at vlsE. The only genes that are required in both
organisms are ruvA and ruvB, which encode subunits of a Holliday junction branch migrase. Disruption of these genes
results in a dramatic decrease in vlsE recombination with a phenotype similar to that observed for lp28-1 or vls-minus
spirochetes: productive infection at week 1 with clearance by day 21. In SCID mice, the persistence defect observed with
ruvA and ruvB mutants was fully rescued as previously observed for vlsE-deficient B. burgdorferi. We report the requirement
of the RuvAB branch migrase in recombinational switching at vlsE, the first essential factor to be identified in this process.
These findings are supported by the independent work of Lin et al. in the accompanying article, who also found a
requirement for the RuvAB branch migrase. Our results also indicate that the mechanism of switching at vlsE in B.
burgdorferi is distinct from switching at pilE in N. gonorrhoeae, which is the only other organism analyzed genetically in
detail. Finally, our findings suggest a unique mechanism for switching at vlsE and a role for currently unidentified B.
burgdorferi proteins in this process.
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Introduction
Antigenic variation through targeted genome rearrangements is
a common strategy for immune evasion and has been identified in
many important pathogens including protozoa [1,2,3,4], bacteria
[5,6,7,8,9,10,11] and fungi [12]. In spite of the common
occurrence of this strategy for immune evasion amongst
pathogens, few molecular details of the recombinational switching
processes that generate diversity in antigen-expressing genes have
been reported for any organism.
Lyme borreliosis is a world wide health problem. It is a
multisystemic illness caused by the spirochete Borrelia burgdorferi,
and related species. Disease progression occurs through three
stages: early, disseminated and persistent and can result in various
arthritic, cardiac and neurological concerns if left untreated
[13,14,15]. Persistent infection by B. burgdorferi requires continual
segmental gene conversion at the vlsE locus, which encodes a
35 kDa membrane lipoprotein [9,16,17,18,19]. The vlsE gene, or
expression locus is carried at the right end of the linear plasmid
lp28-1. In the absence of lp28-1 or when the vls locus is deleted a
productive murine infection ensues, but the spirochetes are cleared
between days 8 and 21 post-infection [16,17,20,21]. Adjacent to
vlsE (also referred to as vls1), is a contiguous upstream array of 15
silent cassettes separated from each other by 17 bp direct repeats,
which also flank the vlsE variable region (see Fig. 1C in [18]).
During murine infection (and probably in other mammals)
information is transferred unidirectionally from the silent cassettes
into the expression site to generate diversity at six regions (VR1–
VR6) within the central region of the vlsE gene [17,18,19]. These
regions correspond to highly exposed regions of the VlsE protein
and are believed to be prominently displayed antigenic areas [22].
Generation of antigen diversity occurs through segmental gene
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be transferred into the single vlsE locus to generate a mosaic gene
with possibilities for the production of myriad unique VlsE
proteins. All silent cassettes are utilized as sequence donors in the
gene conversion events at vlsE and the majority of recombination
events are short, ranging from 1–22 codon changes [17]. Similarly,
the requirement for flanking sequence homology is also short, in
the neighborhood of approximately 10 nucleotides.
An interesting feature of switching at vlsE is that it does not
occur when spirochetes are grown in culture or when they reside
in the tick midgut. [18,23]. Moreover, the acquired immune
response is not required, as switching occurs in SCID mice, which
lack the ability to mount an acquired immune response to
antigenic challenge [9,16,17,20]. The mammalian signal that
triggers recombinational switching remains unknown at this time.
These features make the study of antigenic variation in B.
burgdorferi difficult and limit these studies to animal infection
models. In the mouse, antigenic switching can be detected four
days after infection and by 28 days no parental vlsE sequences
remain in the population of spirochetes recovered from some
tissues in infected animals [9,17,20].
Even though B. burgdorferi has a small genome [24,25],
genetic manipulation is time consuming, inefficient and
sometimes difficult [26]. The protein machinery that promotes
recombinational switching at vlsE is, therefore, unknown at this
time. A single study towards this end has reported that the B.
burgdorferi recA gene is not required for antigenic switching [27].
In this study we generated 17 mutants carrying disruptions in
known DNA recombination, repair and replication genes in the
hopes of identifying proteins involved in recombinational
switching at vlsE. A single recombination function, the RuvAB
Holliday junction branch migrase encoded by the ruvA and ruvB
genes, was unambiguously identified as a requirement for
switching at vlsE, a result also reported in the accompanying
paper by Lin et al [28]. In contrast, 10 known recombination,
repair, or replication genes are required in recombinational
events underlying antigenic switching at pilE in N. gonorrhoeae
[29,30,31,32,33,34,35,36,37,38,39]. Eight of those genes are
either missing or not required for switching at vlsE in B.
burgdorferi. Our results point towards a unique mechanism for
switching at vlsE in and suggest that it may involve specialized
proteins that help to mediate the process.
Results
Construction of DNA repair and replication gene
disruptions in B. burgdorferi
A systematic approach was undertaken to disrupt 21 different
genes in order to investigate their role in vlsE recombination in B.
burgdorferi. Knockout plasmids were constructed (Figure S1) and
used to transform the infectious B. burgdorferi B31 clone 5A4 [40].
Following transformation, allelic exchange results in successful
gene disruption (Fig. 1A). However two other transformation
outcomes can arise: integretative recombination, which results in
merodiploid formation, and cases where no recombinants are
recovered [26]. To investigate the structure of the B. burgdorferi
transformants, they were screened using PCR with various primer
combinations (Fig. 1B). The presence of the gentamicin resistance
cassette (Panel 1) and the absence of the expected deleted
sequences (,500 bp) from the disrupted target gene (Panel 2)
were first confirmed using the indicated primer sets. The target
gene was also amplified (Panel 3) to confirm the approximate
0.7kb size increase relative to wild-type DNA due to the insertion
of the gentamicin resistance cassette. Finally, the correct insertion
site was verified using combinations of the target and knockout
primers to amplify the insertion boundaries (Panel 4). In addition
to the PCR analyses, gene disruptions were independently
confirmed by Southern hybridizations using probes specific to
the gentamicin resistance cassette and the deleted portion of the
target gene (see Fig. S2 and Table S2).
Of the 21 DNA replication, repair and recombination gene
knockouts attempted, 17 were successful (Table 1). When a
disruption attempt was unsuccessful, the knockout plasmid was
re-constructed in an effort to minimize possible effects on
adjacent gene expression from read-through of transcription
from the gent cassette. This was accomplished by either changing
the polarity of the gentamicin resistance cassette relative to the
gene target, or by adding (or removing) a T7 transcriptional
terminator. Three gene targets required reconstruction of the
knockout plasmid in order to successfully obtain B. burgdorferi gene
disruptions. recJ was first attempted without the T7 terminator in
the reverse orientation and resulted only in merodiploids. The
gentamicin resistance cassette in the forward orientation with the
T7 terminator did result in knockouts and further attempts were
halted. The sbcD knockout was first attempted with a construct
containing the T7 terminator and the gentamicin resistance
cassette in the reverse orientation. This attempt resulted only in
merodiploids; however, when the polarity was changed to the
forward orientation, allelic exchange was successful. The recA
disruption was also difficult to obtain. Unsuccessful attempts were
first made with the gentamicin resistance cassette in the forward
orientation with and without the T7 terminator. When the T7
terminator was removed and the gent gene was in the reverse
polarity, true knockouts of the recA gene were obtained. Difficulty
in obtaining a recA gene disruption has also been previously
reported [41], however, a single recA null mutant has been
previously constructed with the insertion of a kanamycin
resistance cassette in the forward orientation [27]. Finally, dnaB,
hbb, recB and recC knockouts were not obtained despite changing
the polarity of the gentamicin resistance cassette and adding or
removing a T7 transcriptional terminator.
Effect of B. burgdorferi gene disruptions on C3H/HeN
mouse infections: an essential role for ruvAB in
recombinational switching
For each gene disruption two clones were chosen which
contained the full plasmid complement required for infectivity,
Author Summary
A common strategy for evasion of the host immune
system is the continuous variation of a major surface
protein that elicits a dominant immune response (anti-
genic variation). Many pathogens accomplish this goal by
unidirectional movement of DNA sequence information
from silent or archival gene copies into an expression site.
The molecular details of how this gene shuffling is
accomplished are not understood for any organism. In
the flat-wave shaped bacterium causing Lyme disease,
information is moved from 15 silent cassettes into the vlsE
gene to promote antigenic variation. In this work we have
investigated the effect of independent mutation of 17
DNA replication, recombination and repair genes on the
movement of genetic information into vlsE. We found that
mutation of either of the genes encoding the two subunits
of the RuvAB branch migrase blocked transfer of genetic
information into vlsE during mouse infections, identifying
the first required function for antigenic variation in the
Lyme disease spirochete.
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PLoS Pathogens | www.plospathogens.org 2 December 2009 | Volume 5 | Issue 12 | e1000680Figure 1. Gene disruption and confirmation. A) Gene disruption strategy. The infectious B. burgdorferi strain B31, clone 5A4 (B31-5A4) was
transformed with a knockout plasmid carrying a one kb gentamicin cassette (blue) that replaced the central portion of the target gene (yellow) as
described in Materials and Methods. The two possible outcomes of recombination events with the target gene are shown: allelic exchange would result
in genedisruption whileintegrativerecombinationoftheknockout plasmidwouldresultin merodiploidformation. Thepositionof PCRprimers used for
construct verification are shown by arrows on the schematic. B) Construct verification of the mutL disruption by PCR. Each gene disruption was
subjected to four PCR analyses. 1) The presence of the gentamicin resistance cassette was confirmed as shown in lanes 1 and 2. The shuttle vector
pBSV2G [71] served as the positive control c
+ for amplification of the gent cassette (lane 3.) 2) The portion of mutL expected to be deleted in a gene
disruptionwas notdetectedineithermutL1 or2 (lanes5and6);however,itwasdetectedinthepositivecontrol(c+),whichcontainedwild-typeB31-5A4
DNAas a templatein lane 7.3)Thesizeofthetargetgenewas compared in mutL1 and2 genotypes. Theexpected2.1 kbproductsfora genedisruption
were observed (lanes 9 and10) in comparison to the 1.5 kb product from the mutL
+ genotype (lane 11). Lanes 4, 8 and12 arenegative controls (c
2)t h a t
lackedDNAtemplate. 4)Confirmationof the correct insertionsitewasperformedusing combinations of thetargetgene primers andprimersinternal to
thegentamicincassettetoamplify theboundaries.TheleftboundaryinbothmutLclonesgavetheexpected0.55 kbproduct (lanes13and15).Theright
boundary in both clones gave the expected product of approximately 1.3 kb (lanes 14 and 16). A 100bp ladder on the left side, relevant to the two left
panels, and a 1kb ladder on the right side, which applies to the two right panels, were the molecular weight markers (M) used.
doi:10.1371/journal.ppat.1000680.g001
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plasmids. Most mutant constructs contained the full complement
of plasmids found in the parental clone B31 5A4 [40]. Some of the
mutant B. burgdorferi clones lacked plasmids that are not required
for infection or persistence as follows: recJ1 lacks lp28-2, mag2 lacks
lp28-4, ruvA1 is missing cp9, mutL2 lacks cp9 and cp32-3, nucA1
lacks lp21 and cp32-3, ruvB5 lacks lp28-4 and cp9 and priA3, recA2
and recA3 are missing cp9. The possible effect of the mutations on
growth of B. burgdorferi in culture was assessed by performing
growth comparisons of each of the mutants with the wild-type
clone 5A4. All mutants displayed growth curves that were
indistinguishable from the parent strain (data not shown).
Two independent knockout clones for each mutation were used
to infect C3H/HeN immunocompetent mice (at least two mice for
each clone, four mice for each mutated gene) as described in
Materials and Methods. Cultures were grown from blood samples
at day 7 to monitor infectivity. At days 14 and 21, by which time
spirochetes are largely cleared from the blood, ear biopsies were
used to monitor infection and switching at vlsE. The upper portion
of Table 2 shows mutant strains that displayed a productive
infection ($75% of mice infected at day 7) that did not decline at
day 21, the point post-infection when strains unable to switch at
vlsE have been cleared [16,17,20,42]. The variable region of vlsE
was amplified from DNA isolated from day 21 ear cultures and
analyzed using RFLP assays (Fig. 2), which detect new restriction
sites resulting from switching at the vlsE locus [16]. As noted in the
upper portion of Table 2, mutS2, recA, recG, rep, nucA, mag, mfd and
nth mutants all displayed switching at the vlsE locus.
The lower portion of Table 2 shows mutant strains that
displayed ,75% positive cultures from ear biopsies at day 21.
When spirochetes could be cultivated at day 21 (sbcD, sbcC and
BBG32) switching was monitored and shown to occur using the
RFLP assay. For the remainder of the mutant strains, infections
were allowed to continue until day 35. At this time the mice were
euthanized and spirochetes cultivated from heart, bladder, joint
and ear. RFLP switching assays indicated that switching at vlsE
had occurred in all mutant strains from tissues where spirochetes
could be recovered at day 35, with the exception of those carrying
the ruvA or ruvB mutations, whose functional genes encode the two
subunits for a Holliday junction branch migrase [43,44,45].
Although the ruvA and ruvB mutant strains recovered from organ
harvest at day 35 were negative for switching by RFLP, DNA
sequencing analysis revealed that switching had occurred at low
efficiency (data not shown).
Table 1. Gene disruption targets and knockout plasmid attributes.
Gene target Locus Gene description Plasmid
E. coli strain
number (GCE)
Polarity of gent
relative to target
T7
terminator
Gene
disruption Merodiploid
recJ BB0254 ssDNA-specific exonuclease
pAD51
pAD26
1563
1538
forward
reverse
+
2
+
2
2
+
priA BB0014 helicase pAD94 1908 forward ++2
sbcD BB0829 exonuclease
pAD87
pAD86
1599
1598
forward
reverse
+
+
+
2
2
+
ruvA BB0023 Holliday junction helicase pAD78 1590 forward ++2
mutL BB0211 mismatch repair protein pAD61 1573 forward ++2
ruvB BB0022 Holliday junction helicase pPOH6 1618 forward 2 + 2
sbcC BB0830 exonuclease pAD65 1577 forward ++2
BBG32 BBG32 putative helicase pAD88 1900 forward ++2
mutS1 BB0797 mismatch repair protein pPOH2 1604 forward 2 + 2
mutS2 BB0098 mismatch repair protein pAD24 1536 reverse 2 + 2
recA BB0131 DNA-dependent ATPase
pAD101
pAD92
pAD102
1913
1904
1914
reverse
forward
forward
2
+
2
+
2
2
2
2
2
recG BB0581 ATP-dependent helicase pAD49 1561 reverse ++2
rep BB0607 ssDNA-dependent ATPase helicase pAD53 1565 reverse ++2
nucA BB0411 exonuclease involved in competency pAD63 1575 forward ++2
mag BB0422 39-methyladenine DNA glycosylase pAD57 1569 forward ++2
mfd BB0623 transcription-repair coupling factor pAD59 1571 reverse ++2
nth BB0745 endonuclease III pPOH28-5 1684 reverse 2 + 2
dnaB BB0111 replicative helicase
pAD80
pAD81
1592
1593
forward
reverse
+
+
2
2
2
2
hbb BB0232 DNA-binding protein
pAD100
pAD99
pAD106
1912
1911
1918
reverse
forward
reverse
+
+
2
2
2
2
2
2
2
recB BB0633 exonuclease
pAD22
pAD48
1534
1560
reverse
reverse
2
+
2
2
2
2
recC BB0634 exonuclease
pAD84
pAD104
pAD103
1596
1916
1915
reverse
forward
reverse
+
2
2
2
2
2
2
2
2
doi:10.1371/journal.ppat.1000680.t001
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HeN mouse infections
Mutants of B. burgdorferi strains that did not show switching in
wild-type C3H/HeN mice using the RFLP assay (ruvA and ruvB)
and five other mutants that displayed a decreased persistence at
day 21 (recJ, mutL, sbcC, sbcD and BBG32) were used to infect SCID
C3H/HeN mice, which lack an acquired immune response. This
effectively removes the selective pressure on antigenic variation
and allows B. burgdorferi mutants with defective switching at vlsE to
persist in the host. Direct analysis of vlsE switching beyond 21 days
post-infection can, therefore, be performed in SCID mice, whereas
by this time non-switching spirochetes would be cleared in a wild-
type mouse [16,17,20,42]. All the mutant strains tested displayed
wild-type levels of infectivity and persistence throughout the 35
day course of infection in SCID mice (Table 3). This indicated
that the ruvA and ruvB mutant strains, which did not switch in wild-
type mice using the RFLP assay and which showed greatly
reduced levels of persistence at day 21 (Table 2, bottom), were
fully competent for the infection process in mice lacking an
acquired immune response. The other mutant B. burgdorferi strains
that displayed reduced infectivity and persistence were also fully
rescued in mice lacking an acquired immune response.
Analysis of switching at vlsE by DNA sequencing of
mutant strains recovered from SCID mouse infections
The RFLP assay used here provides a quick and convenient
assay method to detect switching at vlsE [16]. The incorporation of
new restriction endonuclease sites from the silent cassettes into the
variable region of vlsE is a clear indicator of the switching process.
However, the fact that the assay is not quantitative, coupled with
the observation that switching is apparently less frequent in SCID
mice [17], led us to further analyze switching in SCID mice in a
limited set of mutants by DNA sequencing. We chose the two
mutants that were negative for switching in wild-type mice by
RFLP analysis (ruvA and ruvB) as well as two mutants that were
shown to switch by RFLP at 35 days in wild-type mice, but that
displayed no spirochetes in ear cultures at 21 days (recJ and mutL).
For DNA sequencing studies the same PCR product used for
the RFLP assay (a 776 bp fragment containing the vlsE variable
region) was amplified from the spirochetes recovered from four
different tissue types at day 35 for each SCID mouse and gel
purified (see Material and Methods). Equimolar amounts of the
vlsE PCR product from each tissue from the 4 mice used in the
infections were combined, providing four pools for each disrupted
gene: heart, bladder, joint and ear. The pools were cloned and 10
E. coli clones were chosen for each tissue type for a total of 40 vlsE
sequences examined for each of the recJ, mutL, ruvA, ruvB and wild-
type genotypes. Using a primer specific to the cloning vector, the
plasmid DNA was sequenced and compared to the B. burgdorferi
5A4 parental vlsE sequence for both templated (present in a silent
cassette) and non-templated nucleotide changes [17,19]. Each
sequenced clone where switching at vlsE had occurred displayed a
unique sequence; hence, all switch variants from each mouse
represented independent switching outcomes.
Sequencing revealed that 10 out of 10 wild-type clones
contained nucleotide changes corresponding to sequences found
in the silent cassettes in the heart and bladder tissue cultures while
5/10 and 8/10 clones had switched in the joint and ear tissues,
respectively (see Fig. 3). These results are similar to previously
reported data which indicated a greater proportion of switched
clones in heart, bladder and skin tissues than in joint and ear
tissues [17]. The overall switching frequency that we observed
(82.5% at day 35 post-infection in SCID C3H/HeN mice) also
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recently observed [17]. For proper analysis, a tissue-specific
comparison between mutants and wild-type spirochetes was
undertaken as shown in Fig. 3.
The most significant reduction in switching occurred with ruvA
and ruvB mutants with only one of 40 clones (2.5%) differing from
the wild-type vlsE sequence in ruvA and no changes observed in
any of the 40 ruvB clones. The single clone demonstrating
switching at vlsE in the ruvA mutant was from a clone cultivated
from joint that displayed at least four exchanges with silent
cassettes and did not show any features with obvious differences
from switching in wild-type B. burgdorferi. The P-values indicated a
significant difference (,0.05) in the incidence of switching for all
tissues, with the exception of the ruvA mutant in joint. These results
corroborated the negative switching phenotype of the ruvA and
ruvB mutants observed in the RFLP switching assay after infection
of wild-type and SCID mice (Tables 2 and 3). The results are
further strengthened by the fact that ruvA and ruvB encode the two
subunits of an enzyme known to promote branch migration of
Holliday junction recombination intermediates.
Clones carrying a mutL mutation displayed an intermediate
phenotype with a decrease in switching resulting in a total of only
27.5% of the clones exhibiting nucleotide changes, versus 82.5%
for wild-type. Significant tissue-specific differences were observed
in the bladder and heart but not the joint and ear (Fig. 3). recJ
showed a slight change in the level of switching with 57.5% of the
clones displaying changes in the vlsE variable region compared to
85% for wild-type. A significant difference in tissue-specific
Figure 2. Restriction fragment length polymorphism assay for switching at vlsE. A portion of the vlsE expression site containing the
variable regions was amplified using primers B248 and B249 to give a product of 776 bp. PCR reactions were performed on B. burgdorferi grown from
ear biopsies taken at day 21 and the products were digested with HphI and run on a 1.2% agarose gel in TAE buffer at 75V for 1.5 hours and stained
with ethidium bromide (see Materials and Methods). Wild-type B. burgdorferi B31-5A4 recovered following infection of a C3H/HeN mouse was used as
a template in lanes 1 and 2. An unswitched template (not exposed to mouse infection) is shown in lanes 3 and 4. PCR products from rep2 and mutS2/
1 DNA templates are found in lanes 5 & 6, and 7 & 8 respectively. M denotes a 100bp molecular weight marker.
doi:10.1371/journal.ppat.1000680.g002
Table 3. Effect of DNA repair and replication mutations on B. burgdorferi infection in SCID C3H/HeN mice.
B. burgdorferi
genotype
Strain
(GCB)
Total
micea
Day 7
Bloodb
Day 7
Infection
Day 21
Ear
Day 21
Infection Day 35
Persistence
at day 35
Heart Bladder Joint Ear
Total
sites
c
5A4 wt 933 6 6/6 100.0% 6/6 100.0% 6/6 6/6 6/6 6/6 24/24 100.0%
recJ1 (BB0254)
recJ5
1153
1154
4
2/2
2/2
100.0%
2/2
2/2
100.0%
2/2
2/2
2/2
2/2
2/2
2/2
2/2
2/2
8/8
8/8
100.0%
ruvB4 (BB0022)
ruvB5
513
514
4
2/2
2/2
100.0%
2/2
2/2
100.0%
2/2
2/2
2/2
2/2
2/2
2/2
2/2
2/2
8/8
8/8
100.0%
ruvA1 (BB0023)
ruvA2
1174
1175
4
2/2
2/2
100.0%
2/2
2/2
100.0%
2/2
2/2
2/2
2/2
2/2
2/2
2/2
2/2
8/8
8/8
100.0%
mutL1 (BB0211)
mutL2
1178
1179
4
1/2
1/2
50.0%
2/2
2/2
100.0%
2/2
2/2
2/2
2/2
2/2
2/2
2/2
2/2
8/8
8/8
100.0%
sbcD1 (BB0829)
sbcD2
1251
1252
4
2/2
2/2
100.0%
2/2
2/2
100.0%
2/2
2/2
2/2
2/2
2/2
2/2
2/2
2/2
8/8
8/8
100.0%
sbcC2 (BB0830)
sbcC3
1248
1249
4
2/2
2/2
100.0%
2/2
2/2
100.0%
2/2
2/2
2/2
2/2
2/2
2/2
2/2
2/2
8/8
8/8
100.0%
BBG32/6
BBG32/7
1233
1234
4
2/2
2/2
100.0%
2/2
2/2
100.0%
2/2
2/2
2/2
2/2
2/2
2/2
2/2
2/2
8/8
8/8
100.0%
aTotal number of mice examined for genotype.
bValues listed correspond to number of cultures positive/number of sites tested.
cNumber of positive tissue sites/number of sites tested.
doi:10.1371/journal.ppat.1000680.t003
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data were also analyzed by counting the number of nucleotide
changes in each clone (Table S3) and gave similar results (see also
Discussion). DNA sequencing was also performed on the vlsE
variable region from infections with sbcC, sbcD and BBG32 B.
burgdorferi mutants, which displayed wild-type switching levels in all
four (sbcC) tissues or in three of the four four (sbcD and BBG32)
tissue types (data not shown).
In addition to the apparent templated nucleotide changes
observed in switches at vlsE, some non-templated changes
(NTCs), where new sequence at vlsE did not correspond to the
sequence found in any of the silent cassettes, were also observed
[17,46]. There were no NTCs in the total of 80 vlsE sequences
analyzed for wild-type and ruvB clones. In ruvA,f o u rN T C s
were observed in non-switching clones and three in the single
clone that switched. In the mutL m u t a n tt h e r ew e r ef i v eN T C s
and all of these occurred in clones that did not switch. Finally
the recJ heart sample had six NTCs in three clones, two of
which switched. Taken together there were a total of 18 NTCs
in the ruvA, mutL and recJ mutants.
Discussion
Attempts were made to generate 21 disruptions in B. burgdorferi
genes believed to be involved in DNA recombination, repair and/
or replication to investigate their possible roles in recombinational
switching at the vlsE locus. Seventeen genes were successfully
disrupted. Three of these gene disruptions (recJ, sbcD and recA)
required either reversing the polarity of the gentamicin resistance
cassette or adding (or removing) a T7 transcriptional terminator.
Previous attempts at recA insertional mutation have either been
unsuccessful [41] or have resulted in a single clone [27]. In this
study multiple recA disruptions were obtained only in the absence
of a T7 terminator and with the aacC1 in the reverse orientation
relative to recA, underscoring the importance of the transcriptional
features (direction of expression and the presence or absence of a
transcriptional terminator) in the drug resistance cassette when
attempting B. burgdorferi gene disruptions. It is also worthy of note
that although our gene disruption mutants carry both an ,500 bp
deletion of the target gene as well as an insertion of the aacC1 gene,
expression of a partial gene product with some level of
functionality cannot be rigorously ruled. Antiserum to the 17
disrupted genes is not currently available and immunoblotting
experiments could therefore not be performed.
In addition to the 17 successful gene disruptions, we were
unsuccessful in obtaining disruptions of dnaB (a replicative
helicase), recB or recC (subunits of a recombinational helicase/
nuclease) and hbb (an accessory factor with properties of E. coli HU
and IHF, which introduces sharp bends in DNA [47,48,49]).
Whether these genes are essential functions for B. burgdorferi,a si s
expected for dnaB, or whether our gene disruption conditions for
these loci are still not ideal remains to be established. The primary
purpose for the construction of mutants described here was to
study the possible role of genes in question on recombinational
switching at the vlsE locus. The effect of the 17 mutations on
generalized recombination and DNA repair is currently under
study and will be reported elsewhere.
Candidate genes involved in antigenic variation were identified
by mouse infections in C3H/HeN and SCID mice. Initial
Figure 3. Number of switched vlsE clones in SCID C3H/HeN
mice. Sequencing of the cloned PCR product of the vlsE variable
regions using primer pJET1.2/forward was performed on 10 clones
from each tissue type culture for each genotype (see Materials and
Methods). The y-axis denotes the number of clones out of ten that
contained templated nucleotide changes in variable regions 1–6
(switches) and the x-axis denotes the tissue type. The P-values
a b o v et h eb a r si n d i c a t et h el e v e lo fs i g n i f i c a n c eo ft h ed i f f e r e n c e
between the wild-type and mutant samples, calculated using
Fisher’s Exact test.
doi:10.1371/journal.ppat.1000680.g003
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followed by DNA sequencing of clones recovered from organ
harvest cultures from SCID mice at 35 days post-infection.
Analysis of the number of switching events and the source (silent
cassette) of the new sequences at vlsE is often difficult to establish
due to sequence redundancy in different cassettes and the
complexity of the resulting switch genotypes (see [17]); hence, an
exact method for determining the number of switches in all clones
does not exist. Sequencing data was, therefore, analyzed by two
independent methods. First, the number of clones that contained
switches for each genotype was counted and compared to that of
wild-type B. burgdorferi (Fig. 3). This approach provides informa-
tion on the number of clones where recombinational switching
occurs, but the number of switching events or extent of
recombinational switching in each clone is not considered. The
second method involved counting the number of nucleotide
changes as an approximate indicator of the degree of switching
(Table S3). Because switching events at vlsE usually involve short
stretches of DNA [17], this method is expected to provide a
reasonable estimate of the degree of switching. Although the
binary alternative outcome for the first method results in a
preferred statistical analysis, it is not currently known which of the
two methods of estimating the extent of switching is more
accurate. As discussed below, the data and conclusions from both
methods of analysis were concordant.
Finally, it is noteworthy that other than the ruvAB mutants, which
are required for switching at vlsE, the remainder of the genes we
disrupted were dispensable for animal infection. The major DNA
assault expected by a microbe upon animal infection is oxidative
DNA damage originating from the innate immune response.
However, due to a lack of iron in B. burgdorferi, oxidative damage of
DNA appears to be much lower than in other organisms, such as E.
coli [50]. Hence, DNA repair functions may be less important in
protecting the pathogen from exogenous sources of DNA damage.
Nonetheless, it is of interest that several of the recombination, repair
and replication mutants examined in this study displayed altered
infection phenotypes that were not attributable to an obvious deficit
in vlsE switching in C3H/HeN mice (Table 2). Various levels of
decreased infectivity were observed at days 7, 21 and 35 in
comparison with the 100% infectivity displayed by all 18 wild-type
control mice. Surprisingly, wild-type levels of infectivity for these
mutants was restored in SCID C3H/HeN mice lacking an acquired
immune response (Table 3). The mechanism for decreased
infectivity in wild-type that is rescued in SCID mice remains open
to speculation at this time.
recA is not required for recombinational switching at vlsE
Homologous recombination in bacteria is typically initiated by
RecA-mediated pairing and strand invasion [51,52,53]. It has been
previously reported that a recA gene disruption in B. burgdorferi did not
affect switching at vlsE [27]. Because the recA gene in B. burgdorferi is
not easilydisrupted [41] and because a single clone with the disrupted
genewasusedtoassesstheroleofrecAin recombinationalswitching at
vlsE [27], we constructed several recA knockouts and tested two of
them for switching at the vlsE locus. Our results confirm the previous
findings that recA is not required [27]. This raises the interesting
question of how pairing and strand invasion is initiated for
recombinational switching at the vlsE locus. The lack of a
requirement for the RecA protein, and the unidirectional segmental
gene conversion events that characterize switching at the vls locus in
B. burgdorferi argue for the need of a specialized protein(s) to help
mediate the process. The expendability of RecA for antigenic
variation in B. burgdorferi is also a stark difference from antigenic
variation systems in other organisms, as will be discussed below.
A role for the ruvAB encoded branch migrase in
recombinational switching at vlsE
The RuvAB complex is required for homologous recombination
and facilitates ATP-dependent branch migration of heteroduplex
DNA in Holliday junctions [43,44,45]. RuvA tetramers bind and
unfold the heteroduplex DNA and recruit RuvB hexamers, which
function as a helicase to move DNA through the RuvAB complex.
B. burgdorferi RuvA and RuvB share 32% and 48% identity with
their E. coli orthologues, respectively. ruvAB mutants in E. coli have
only modest defects in homologous recombination. However,
these defects become significant when there are also mutations in
other recombination proteins, such as recBC, recG and sbcBC
[54,55]. The role of RuvAB in DNA repair and recombination has
not been previously investigated in B. burgdorferi.
The observed infection phenotype of both ruvA and both ruvB
mutant strains reported here was as previously observed for strains
lacking either lp28-1 [16,17,20,21] or the vls locus [16,17,20,21],
where switching cannot occur. Infection of wild-type mice was
100% at day 7 with apparent complete clearance at day 21
(Table 2). Complete rescue of the persistence defect for ruv mutant
strains was observed in all cases in SCID mice (Table 3). A
difference in phenotype between strains lacking either lp28-1 or
the vls locus, with those carrying a ruv mutation is that at 35 days
post-infection spirochetes could be recovered in some organ
harvest cultures from wild-type mice infected with the ruv mutants.
DNA sequence analysis revealed that a single switch variant was
present in spirochetes from a given tissue, or from both tissues in
the two mice where positive cultures were recovered from two
sites. These results are indicative of low frequency switching in the
mutants, resulting in occasional survival and selection of a single
switch variant. This phenotype has also been observed by [28].
The phenotype and the dramatic inhibition of switching at vlsE
(Fig. 3) of the strains carrying the ruvA and ruvB gene disruptions
in this study identify the first protein factors involved in switching
and support a mechanism involving branch migration of a
recombination intermediate for antigenic variation in B. burgdorferi.
Although we were unable to complement our ruv mutations (data
not shown), genetic complementation in B. burgdorferi is frequently
difficult to achieve, for reasons not currently understood. We
nonetheless argue for the absence of secondary mutations in the
mutant B. burgdorferi strains based upon the following arguments: 1)
Our studies were performed with two independent mutations in
both the ruvA and ruvB genes. The four independent mutant strains
demonstrated the same phenotype, making the existence of
secondary mutations exceedingly remote. 2) Although not a strict
genetic complementation, the rescue of persistent infectivity in all
four ruv mutants following the infection of SCID mice is
compelling evidence for the absence of any secondary mutations
affecting infectivity. 3) Similar results and conclusions with ruv
mutants made by transposon mutagenesis in the accompanying
idependent study from the Norris lab [28] corroborate the findings
presented here and our combined results provide compelling
evidence for a RuvAB role in switching at vlsE.
A companion protein to RuvAB in most bacteria is the Holliday
junction resolving enzyme RuvC. B. burgdorferi does not encode a
RuvC orthologue and has no characterized junction resolving
enzyme. This leaves unanswered the question of how recombina-
tion intermediates involved in homologous recombination or
switching at vlsE are processed. A series of putative LE family
exonucleases encoded by the cp32 family of circular plasmids has
been proposed as possible substitutes for RuvC in B. burgdorferi
[56]. The actual function of these l exonuclease-type proteins
remains to be established and simultaneous disruption of all of
Effect of Mutations on Switching at vlsE
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methods available for B. burgdorferi.
A possible role for mutL in recombinational switching at
vlsE?
mutL and recJ are both players in bacterial mismatch repair
[57,58,59]. In E. coli MutL acts as a liaison between MutS, which
recognizes the mismatch, and MutH which is responsible for
introducing a nick on either side of the mismatch. Both mutS1 and
mutS2 are present in the B. burgdorferi genome, but disruption of
either gene did not affect the infectivity phenotype in wild-type
mice or switching as assayed by RFLP. There is no identifiable
mutH orthologue in B. burgdorferi [25]. Disruption of mutL resulted
in a modest decrease in switching at vlsE that was significant
(Fig. 3) or near significant (Table S3) in heart and bladder but
not in ear and joint. The results did not allow a clear-cut
conclusion on the involvement of MutL in switching as
demonstrated for RuvA and RuvB. Further analyses will be
required to derive an unambiguous answer to this question. It is
possible that MutL plays a role in recombinational switching at
vlsE, but that another B. burgdorferi protein can substitute for MutL
because of functional redundancy. In such a case a double
knockout will be required for further investigation; however, a
functional paralogue of MutL has not been identified in B.
burgdorferi at this time. It is also possible that the reduction in
switching in mutL mutants results from a decreased level of fitness
and a slower growth rate of the mutant in the mouse (Table 2).
RecJ is a 59 to 39 exonuclease that in E. coli can promote
mismatch excision and prepares DNA for strand invasion by
creating the single-stranded 39-overhang [53]. Disruption of recJ
resulted in a decrease in infectivity in wild-type mice at 21 days
and a modest decrease in switching at vlsE that was significant only
in the heart for both methods of analysis (Fig. 3 and Table S3).
Again, the results did not permit an unambiguous conclusion as to
the possible involvement of RecJ in switching at vlsE. The slightly
decreased vlsE switching phenotype observed in B. burgdorferi could
be a result of redundancy of function for recJ and recD as has been
previously reported in E. coli [60,61]. A recD recJ double mutant, if
viable, might provide further information regarding the role of recJ
in vlsE recombination. Alternatively, the decrease in switching
might simply reflect a decreased level of fitness and infectivity of
the mutant spirochete in the mouse and there may be no direct
role of RecJ in switching at vlsE.
Finally, it is noteworthy that mutL and recJ were the only
genotypes sequenced that also contained non-templated nucleotide
changes (NTCs). mutL had five NTCs while recJ had six for a total
of eleven across 7 clones. The NTCs in this study occurred
predominantly in invariable regions where nucleotide changes are
not normally observed. An explanation for why NTCs were only
observed in mutL and recJ could be due to their involvement in the
mismatch repair pathway. These data suggest that these repair
proteins are normally operative at vlsE to correct mismatches and
would, therefore, normally be temporally and spatially positioned
to play a role in the switching process as well. Recent work on
switching at vlsE has reported that approximately 15% of wild-type
vlsE variants carry NTCs [17]. This was not observed in our
sequencing data with wild-type, ruvA or ruvB mutant clones. We
have no explanation for this discrepancy.
Comparison with other antigenic variation systems
While a wide variety of bacterial and protozoan pathogens
employ antigenic variation systems driven by gene conversion
[5,6], the molecular details of the recombinational events
underlying the process remain largely obscure. Information about
some of the protein factors required for gene conversion events are
available only from studies on the bacterial pathogen N. gonorrhoeae
and the protozoan parasite Trypanosoma brucei. Both of these
organisms require either RecA [37] or paralogues of its eukaryotic
RecA counterpart, Rad51 [62,63]. In contrast, both this study and
a previous one [27] have shown that RecA is not necessary for
switching at vlsE in B. burgdorferi.I nN. gonorrhoeae the recFOR
pathway is also involved and disruptions in recQ, recO, recR or recJ
result in elimination or fairly dramatic reductions in antigenic
variation [30,32,33]. In contrast, B. burgdorferi does not carry recO,
recR or recQ orthologues and disruption of recJ did not demonstrate
a clear role for its encoded protein in switching at vlsE. The
Holliday junction resolution pathway (ruvA, ruvB, ruvC and recG) was
also found to be important in N. gonorrhoeae, with disruptions in
these genes resulting in a dramatic decrease in antigenic variation
[31,32]. In B. burgdorferi we found the RuvAB branch migrase to be
required for switching at vlsE, however, there is no known ruvC
orthologue and disruption of recG, which encodes a helicase that
can function in Holliday junction migration, does not affect
switching at vlsE. In summary, the process of recombinational
switching at the vlsE locus shows very dramatic differences in
protein requirements compared to the antigenic variation process
in N. gonorrhoeae, with only the RuvAB branch migrase in common.
Further studies on the recombinational switching underlying
antigenic variation will be required to unravel the elusive
molecular details of this fascinating process.
Materials and Methods
Bacterial strains and transformation
Infectious Borrelia burgdorferi 5A4, derived from the type strain
B31 [40], was cultivated in BSK-II medium prepared in-house
[64], supplemented with 6% rabbit serum (Cedarlane Laborato-
ries, Burlington, ON, CA)) and incubated at 35uC (with a 1.5%
CO2 environment for plating). Bacterial density was determined
using a Petroff- Hausser Chamber (Hausser Scientific Partnership)
and dark-field phase contrast microscopy with a Nikon Eclipse
E400 microscope. E. coli DH5a was used for all knockout plasmid
construction and maintenance. B. burgdorferi 5A4 were transformed
as previously described with 25–50 mg of knockout plasmid DNA
[65,66]. Following transformation, the cell suspensions were
immediately added to 10ml of pre-warmed BSK II supplemented
with 6% rabbit serum. The transformations were allowed to
recover for 24 hours at 35uC with 1.5% CO2. Recovery cultures
were added to BSK II with 6% rabbit serum to a final volume of
50–100 ml and supplemented with 200 mg/ml gentamicin after
which 250 ml aliquots were distributed into 96-well plates and
incubated at 35uC and 1.5% CO2 until some wells with a visible
color change from red to yellow were observed, usually between
8–12 days. Yellow wells were chosen for PCR analysis.
Knockout plasmid construction
Primers for amplifying a centrally located ,1500 bp portion in
the gene of interest were designed according to the published
sequence information (accession numbers NC_001318 and
NC_001852) [25]. The target was amplified by PCR using
Phusion High-Fidelity DNA Polymerase (Finnzymes), used for all
subsequent PCRs unless otherwise noted using 80ng of genomic
DNA template from B. burgdorferi B31 5A4 [40]. In early
experiments the PCR product was cloned into the pJET1.2/blunt
vector (Fermentas) and subsequently into the pCR BluntII-TOPO
vector (Invitrogen). Plasmid DNA was isolated using the GeneJet
Plasmid Miniprep Kit (Fermentas). Inverse PCR was employed to
generate the knockout plasmid backbone [26]. Outward-oriented
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designed within the target gene such that the amplicon produced
did not contain approximately 500bp from the center of the target
gene (see Fig. S1). The inverse PCR product was purified using
the QIAquick PCR Purification Kit (Qiagen). The flgB promoter-
driven gentamicin resistance cassette (aacC1) was used to disrupt
the B. burgdorferi target gene. This cassette was incorporated into
the knockout plasmid by amplifying the flgB promoter-driven
gentamicin resistance gene from the plasmid shuttle vector
pBSV2G [67] using primers B415 and B416 containing 59 Nhe
I sites. A gentamicin resistance cassette with a T7 transcriptional
terminator (59 CTG CTA ACA AAG CCC GAA AGG AAG
CTG AGT TGG CTG CTG CCA CCG CTG AGC AAT AAC
TAG CA TAA CCC CTT GGG GCC TCT AAA CGG GTC
TTG AGG GGT TTT TTG 39) was also used. This cassette was
constructed using overlap extension PCR. The gentamicin
resistance gene was amplified from pBSV2G using primers B820
and B1350, and the T7 terminator, originally from the pGEM-T
easy vector (Promega), was amplified from a plasmid construct
(pTAKanT7t) generously provided by Scott Samuels using
primers B1349 and B1345. Following NheI (New England
BioLabs) digestion the gentamicin resistance cassette and knockout
plasmid backbone were ligated and used to transform DH5a, with
selection using 10mg/ml gentamicin, with the addition of 50mg/ml
kanamycin when the pCR BluntII-TOPO vector was used.
Confirmation of B. burgdorferi gene disruption
Transformants were analyzed by PCR to identify clones with
bona fide gene disruptions and to distinguish them from
merodiploids. PCR was performed using Taq polymerase (New
England BioLabs) and a combination of primers to confirm
legitimate allelic exchange (see Fig. 1). Primers B348 and B349
were used to amplify the gentamicin resistance cassette, the
knockout primers (KO/f and KO/r) for each mutant were used to
confirm gene disruption. The target gene primers (target/f and
target/r) for each mutant were used to confirm the correct
insertion size upon recombination. Finally, primers B349 and
B1281 were used in conjunction with the target primers to verify
the correct insertion site and integrity of the recombination
boundaries.
Southern hybridization analysis was used for verification of
legitimate allelic exchange in the mutants selected for further
study. Approximately 600ng of genomic DNA, prepared using the
Wizard Genomic DNA Purification Kit (Promega) or mini-
genomic DNA preps [68], was digested with HindIII (New
England BioLabs) and separated on a 1.2% agarose gel run at 75V
for 1.5 hours. After staining with 0.5mg/ml ethidium bromide to
confirm complete enzymatic digestion the DNA was depurinated,
denatured and neutralized as previously noted [69]. DNA was
transferred to membranes (Hybond-N+ Amersham) and cross-
linked using the UV Stratalinker 1800 (Stratagene). The gent
probes were prepared from the PCR product of pBSV2G using
primers B348 and B349. The KO/f and KO/r primers specific to
each mutant were used to generate the probes using PCR from the
genomic DNA of B. burgdorferi 5A4. The probes were labeled with
[a-
32P] dCTP by random primer labeling with a Random Primers
DNA Labeling System Kit (Invitrogen). Standard procedures were
used to pre-hybridize, hybridize and wash the blots [69], after
which they were exposed to phosphor screens and analyzed with a
Cyclone Phosphoimager (Packard). PCR analysis of plasmid
content was performed as previously described to ensure the
mutant clones contained the full plasmid complement required for
infectivity [40,70].
Mouse infections
All animal infections were carried out in accordance with
approved protocols from the University of Calgary Animal
Research Centre and were approved by the University of Calgary
Animal Care Committee. Three to four week old male C3H/HeN
(wild-type) or three to five week old male C3H.C-Prkdc
SCID/
IcrSmnHsd (SCID) mice (Harlan, Indianapolis, IN) were inocu-
lated with 200 mlo f1 610
4 spirochetes/ml, in two 100 ml doses via
dorsal subcutaneous and intraperitoneal injection. At seven days
post-infection, 50 ml of blood was taken from the saphenous vein
on the hind leg of the mouse under aseptic conditions. The
exposed vein was opened using a needle prick and the pooled
blood was drawn with a pipette. The pipette tip used to draw the
blood was first coated with 0.5M EDTA to prevent clotting. The
blood sample was suspended in 1.7ml BSK II supplemented with
6% rabbit serum and 16 Borrelia antibiotic cocktail (20 mg/ml
phosphomycin, 50 mg/ml rifampicin and 2.5 mg/ml amphotericin
B) and cultivated as described above. Ear biopsies were performed
at days 14 and 21 and the recovered material was cultivated in
1.5ml of BSK II supplemented with 6% rabbit serum and 16B.
burgdorferi antibiotic cocktail for one to five weeks. The presence or
absence of spirochetes was periodically monitored by dark-field
microscopy. When necessary, a 35 day organ harvest was
performed and the heart, bladder, joint and ear biopsy samples
were removed aseptically and cultured in 1.7ml of BSK II
supplemented with 6% rabbit serum as noted above.
vlsE switching assay
Switching at the vlsE locus was determined by a restriction
fragment length polymorphism (RFLP) assay using the 775 bp
product of PCR amplification of the vlsE expression site using
primers B248 and B249 [16]. This crude switching assay was
performed on week three ear biopsy cultures when available, or on
week 5 organ harvest cultures. Phusion polymerase (Finnzymes)
was used for PCR and the product was purified using the
QIAquick PCR Purification Kit (Qiagen). Approximately 200ng
of PCR product was digested with 2 units of HphI (New England
BioLabs) for 1.5 hours. Reaction products were analyzed on a
1.2% agarose gel run at 75 V for 1.5 hours in Tris-acetate buffer,
stained with 0.5 mg/ml ethidium bromide and images acquired
using a FluorChem 8900 imaging system.
vlsE cloning and sequencing
For detailed analysis of switching at vlsE, mutant B. burgdorferi
strains were used to infect C3H/HeN SCID mice. Switching in
SCID mice was characterized through sequencing of the variable
regions of the vlsE expression site. PCR amplification was
performed using primers B248 and B249 on 1ml of BSK-II
cultures, grown to a density of 1610
6 spirochetes/ml, taken from
glycerol stocks of the heart, bladder, joint and ear organ harvests
for each mouse. Reaction conditions were as follows: 98uC for
2 minutes, 28 cycles of 98uC for 10 seconds and 72uC for
30 seconds, followed by a final extension of 72uC for 5 minutes.
PCR products were visualized and quantified on a 1% agarose gel
run in TAE buffer at 75V for 1.5 hours, stained with 0.5 mg/ml
ethidium bromide. Equimolar portions of the PCR product from
each of the four mice (two mice for each clone) and each tissue
type were combined to give a total of four samples: heart, bladder,
joint and ear for each genotype investigated. These PCR products
were run on a 1% agarose gel and the 775 bp PCR product was
excised and gel purified using the Qiagen Gel Extraction Kit
(Quiagen). The PCR fragments were cloned into the pJET1.2/
blunt vector (CloneJet, Fermentas) and used to transform E.coli
DH5a. The transformations were plated on LB agar plates
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sequencing, 10 colonies of each tissue type for each mutant were
picked and grown in five ml LB supplemented with100 mg/ml
carbenicillin for a total of 40 samples from each genotype. These
cultures were grown overnight at 37uC and plasmid DNA was
isolated using the Qiagen 96 Turbo miniprep kit (Qiagen). The
University of Calgary Core DNA Services sequenced 500 ng
of the plasmid DNA with the pJET1.2forward sequencing primer
(CloneJet, Fermentas) in a 96 well format using an Applied
Biosystems 3730XL 96 Capillary Sequencer (http://www.
ucalgary.ca/dnalab/).
Analysis of sequencing results
Alignmentscomparingthe clonedvlsE sequencing resultsforeach
tissue type in each mutant to the parental vlsE sequence of
B.burgdorferi 5A4 were performed using the Seqman DNASTAR-
Lasergene v6 Software. Templated nucleotide changes, those
corresponding to the sequence of at least one silent casette, were
counted in each variable region as well as the invariable regions and
noted (Table S3). Additionally, non-templated changes were
documented (data not shown). It is important to note that each of
the 10 sequences obtained for each tissue type for each mutant were
different and, therefore, all sequenced clones represented complete-
ly independent switching outcomes. Results were analyzed on a
tissue-specific basis via two methods (Fig. 3). The first method took
into account how many clones from each tissue type switched and
how many retained the parental vlsE sequence. The two-tailed
Fisher’s Exact test was used to determine the P-values of the mutant
switch events (GraphPad Prism). The second method used to
analyze switching was a comparison of data based on the number of
nucleotide changes in each tissue for each mutant (Table S3). A
two-tailednon-parametric Mann-Whitney student t-test was used to
determine the P-values of these data (Graph Pad Prism).
Supporting Information
Figure S1 Strategy for the construction of knockout plasmids.
Construction of the knockout plasmids was accomplished by PCR
amplification of an approximate 1.5 kb central portion of the
target gene (yellow) inserted into a commercial blunt-end cloning
vector. Inverse primers (see Materials and Methods and Table S1)
with NheI sites were used to amplify the vector and target gene
minus a central ,0.5 kb portion of the target gene. Following
digestion with Nhe I the product of the inverse PCR reaction was
ligated to a gentamicin resistance cassette under the control of the
flgB promoter (blue) with Nhe I sticky ends. The knockout
plasmids were propagated in E. coli strain DH5a.
Found at: doi:10.1371/journal.ppat.1000680.s001 (0.24 MB PDF)
Figure S2 Gene disruption was demonstrated by PCR analysis
(see Fig. 1B) and subsequently confirmed by Southern hybridiza-
tion of genomic DNA. In the Southern blot shown, DNA from
mutL, sbcD and ruvA disruptions was digested with HindIII and run
on a 1.2% agarose gel with a 1kb molecular weight ladder (M).
Probes complementary to the gentamicin resistance cassette were
used to probe for the gent insertion (left panel). pBSV2G served as
the positive control (c+) and B. burgdorferi 5A4 genomic DNA
served as the negative control (wt). mutL1 and 2, sbcD1 and 2 and
ruvA1 and 2 clones displayed the expected fragments of 5.5kb,
7.4kb, and 2.8kb respectively. In the right hand panel, probes
complementary to the deleted portion of the target gene were
generated using the knockout primers (see Table S1). The
expected size of the hybridization fragments for these blots was
determined based upon the nearest flanking HindIII sites to
targeted gene in the B. burgdorferi B31 genomic DNA sequence
[25]. mutL
+, sbcD
+ and ruvA+ wild type genomic DNA provided the
expected signals of 4.8kb, 6.4kb and 1.7kb respectively. As
expected, no signals were observed for the mutL, sbcD and ruvA
knockout genotypes indicating the central portion of the target
genes was replaced. Equal amounts of DNA were loaded in each
lane.
Found at: doi:10.1371/journal.ppat.1000680.s002 (1.23 MB PDF)
Table S1 Primers used in this study.
Found at: doi:10.1371/journal.ppat.1000680.s003 (0.03 MB PDF)
Table S2 Southern blot analysis.
Found at: doi:10.1371/journal.ppat.1000680.s004 (0.02 MB PDF)
Table S3 Expanded C3H/HeN SCID vlsE aequence data.
Found at: doi:10.1371/journal.ppat.1000680.s005 (0.14 MB PDF)
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